Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Pharmacokinetics (PK) study

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Antares Pharma Inc.
• Treatments: Methotrexate

Criteria

Inclusion Criteria:

• Male or female >18 years of age with diagnosed Rheumatoid Arthritis(RA).

Exclusion Criteria:

• Chronic or acute renal disease

• Any other clinically significant disease or disorder which, in the opinion of the investigator, might put the subject at risk